The third quarter’s GDP growth of 8.4 percent was far beyond expectations, as was the estimate of 7.6 percent growth for the full year 2023-24.

Read More

​ The third quarter’s GDP growth of 8.4 percent was far beyond expectations, as was the estimate of 7.6 percent growth for the full year 2023-24. The third quarter’s GDP growth of 8.4 percent was far beyond expectations, as was the estimate of 7.6 percent growth for the full year 2023-24.  Moneycontrol Latest News Read More  

The third quarter’s GDP growth of 8.4 percent was far beyond expectations, as was the estimate of 7.6 percent growth for the full year 2023-24.

The latest move is a result of the ongoing regulatory action against the payments bank by the RBI. On January 31, the RBI imposed major business restrictions on the Paytm payments bank citing a prolonged history of non-compliance by the Paytm promoters.

Read More

​ The latest move is a result of the ongoing regulatory action against the payments bank by the RBI. On January 31, the RBI imposed major business restrictions on the Paytm payments bank citing a prolonged history of non-compliance by the Paytm promoters. The latest move is a result of the ongoing regulatory action against the payments bank by the RBI. On January 31, the RBI imposed major business restrictions on the Paytm payments bank citing a prolonged history of non-compliance by the Paytm promoters.  Moneycontrol Latest News Read More  

The latest move is a result of the ongoing regulatory action against the payments bank by the RBI. On January 31, the RBI imposed major business restrictions on the Paytm payments bank citing a prolonged history of non-compliance by the Paytm promoters.

Aurobindo Pharma share price today: Fingolimod capsules has an estimated market size of $447.3 million for the twelve months ending January 2024

Read More

​ Aurobindo Pharma share price today: Fingolimod capsules has an estimated market size of $447.3 million for the twelve months ending January 2024 Aurobindo Pharma share price today: Fingolimod capsules has an estimated market size of $447.3 million for the twelve months ending January 2024  Moneycontrol Latest News Read More  

Aurobindo Pharma share price today: Fingolimod capsules has an estimated market size of $447.3 million for the twelve months ending January 2024

Aurobindo Pharma share price today: Fingolimod capsules has an estimated market size of $447.3 million for the twelve months ending January 2024

Read More

​ Aurobindo Pharma share price today: Fingolimod capsules has an estimated market size of $447.3 million for the twelve months ending January 2024 Aurobindo Pharma share price today: Fingolimod capsules has an estimated market size of $447.3 million for the twelve months ending January 2024  Moneycontrol Latest News Read More  

Aurobindo Pharma share price today: Fingolimod capsules has an estimated market size of $447.3 million for the twelve months ending January 2024

Cipla has completed the transfer of its generics business #39;as a going concern on a slump sale basis to Cipla Pharma and Life Sciences Limited#39;, the company told bourses

Read More

​ Cipla has completed the transfer of its generics business #39;as a going concern on a slump sale basis to Cipla Pharma and Life Sciences Limited#39;, the company told bourses Cipla has completed the transfer of its generics business #39;as a going concern on a slump sale basis to Cipla Pharma and Life Sciences Limited#39;, the company told bourses  Moneycontrol Latest News Read More  

Cipla has completed the transfer of its generics business #39;as a going concern on a slump sale basis to Cipla Pharma and Life Sciences Limited#39;, the company told bourses

Geojit is bullish on UNO Minda has recommended buy rating on the stock with a target price of Rs 792 in its research report dated March 01, 2024.

Read More

​ Geojit is bullish on UNO Minda has recommended buy rating on the stock with a target price of Rs 792 in its research report dated March 01, 2024. Geojit is bullish on UNO Minda has recommended buy rating on the stock with a target price of Rs 792 in its research report dated March 01, 2024.  Moneycontrol Latest News Read More  

Geojit is bullish on UNO Minda has recommended buy rating on the stock with a target price of Rs 792 in its research report dated March 01, 2024.

The second half of the session, which begins at 11.30 am, is expected to remain sluggish while holding the underlying bullish trend

Read More

​ The second half of the session, which begins at 11.30 am, is expected to remain sluggish while holding the underlying bullish trend The second half of the session, which begins at 11.30 am, is expected to remain sluggish while holding the underlying bullish trend  Moneycontrol Latest News Read More  

The second half of the session, which begins at 11.30 am, is expected to remain sluggish while holding the underlying bullish trend

The second half of the session, which begins at 11.30 am, is expected to remain sluggish while holding the underlying bullish trend

Read More

​ The second half of the session, which begins at 11.30 am, is expected to remain sluggish while holding the underlying bullish trend The second half of the session, which begins at 11.30 am, is expected to remain sluggish while holding the underlying bullish trend  Moneycontrol Latest News Read More  

The second half of the session, which begins at 11.30 am, is expected to remain sluggish while holding the underlying bullish trend

The second half of the session, which begins at 11.30 am, is expected to remain sluggish while holding the underlying bullish trend

Read More

​ The second half of the session, which begins at 11.30 am, is expected to remain sluggish while holding the underlying bullish trend The second half of the session, which begins at 11.30 am, is expected to remain sluggish while holding the underlying bullish trend  Moneycontrol Latest News Read More  

The second half of the session, which begins at 11.30 am, is expected to remain sluggish while holding the underlying bullish trend

Motilal Oswal is bullish on Triveni Turbine recommended buy rating on the stock with a target price of Rs 570 in its research report dated March 01, 2024.

Read More

​ Motilal Oswal is bullish on Triveni Turbine recommended buy rating on the stock with a target price of Rs 570 in its research report dated March 01, 2024. Motilal Oswal is bullish on Triveni Turbine recommended buy rating on the stock with a target price of Rs 570 in its research report dated March 01, 2024.  Moneycontrol Latest News Read More  

Motilal Oswal is bullish on Triveni Turbine recommended buy rating on the stock with a target price of Rs 570 in its research report dated March 01, 2024.